We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Upper GI
Poster (Digital)
Clinical
Comparison of Lung Doses and Dependent Factors in IMRT, Tomotherapy & 3DCRT Planning of Ca Esophagus
Manasa Penumur, India
PO-1345
Chemoradiation versus chemotherapy alone in locally advanced biliary cancer. A meta-analysis.
Silvia Cammelli, Italy
PO-1346
The value of chemoradiotherapy in elderly patients with squamous cell carcinoma of the esophagus
Nils Nicolay, Germany
PO-1349
Quality of life changes in esophageal cancer patients treated with preoperative or Radical ChemoRT
Pramod Kumar Gupta, India
PO-1350
Is EDIC a metric to predict lymphopenia in oesophageal cancer patients?
Amy Case, United Kingdom
PO-1352
MR-Guided stereotactic radiotherapy for pancreatic oligometastases from renal cell carcinoma
Jonna van Vulpen, The Netherlands
PO-1353
Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control
Mauro Loi, Italy
PO-1354
A new algorithm in pancreatic cancer: secondary analysis of three prospective studies
Gian Marco Petrianni , Italy
PO-1356
Stereotactic Body Radiotherapy (SBRT) for unresectable liver metastases. Clinical outcomes.
Luis Alberto Perez-Romasanta, Spain
PO-1358
Implementation of modern radiotherapy in a multimodal approach of locally advanced pancreatic cancer
Sophie Dobiasch, Germany
PO-1359
Chemoradiation of locally advanced biliary cancer. A systematic review.
Silvia Cammelli, Italy
PO-1360
Liver oligometastatic disease in metastatic gastric cancer patients: a population-based cohort study
Tiuri Kroese, Switzerland
PO-1361
Definition, diagnosis, and treatment of OligoMetastatic Esophagogastric Cancer (OMEC)
Tiuri Kroese, Switzerland
PO-1362
stereotactic radiotherapy for oligometastatic esophagogastric carcinoma outcome, prognostic factors
Luciana Di Cristina, Italy
PO-1364
Lutetium-177 Dotatate peptide receptor radionuclide therapy outcomes for neuroendocrine tumours
Mohammed AlHilali, United Kingdom
PO-1365
Inter-observer variation in GTV delineation of esophageal cancer on MR, CT and PET CT
Ajra Secerov Ermenc, Slovenia
PO-1366
The value of standard chemoradiotherapy in elderly patients with adenocarcinoma of the esophagus
Nils Nicolay, Germany
PO-1367
Albumin-Bilirubin (ALBI) score predicts hepatotoxicity after stereotactic ablative radiation therapy
Ji Hyeon Joo, Korea Republic of
PO-1368
Role of palliative radiotherapy in bleeding control in patients with unresectable gastric cancer
Jihane Bouziane , Morocco
PO-1369
Real-World Data of Pancreatic Cancer Treated with Ablative Radiation on a 1.5 tesla MR Linac
Rana Bahij, Denmark
PO-1370
A simplified method for delineation of target volumes in 4D oesophageal cancer radiotherapy
Sarah gwynne, United Kingdom
PO-1371
Stereotactic Radiotherapy In Pancreatic Cancer: An Update Of A National Survey
Marco Lucarelli, Italy
PO-1372
Stereotactic Body Radiotherapy in isolated recurrence of pancreatic cancer after radical surgery
Maria Ausilia Teriaca, Italy
PO-1373
A systematic review of definitive radiotherapy for inoperable, non-metastatic gastric cancer
Amy Case, United Kingdom
PO-1375
Neoadjuvant radiotherapy after chemotherapy for borderline resectable pancreas cancer
RIE ASSO, Brazil
PO-1376
The efficacy of Stereotactic Body Radiotherapy (SBRT) in liver metastases, single-center experience
Ahmed Allam Mohamed, Germany
PO-1377
Isotoxic high-dose SBRT versus CRT for localized pancreatic cancer : a single center evaluation
Martin Manderlier, Belgium
PO-1378
Evaluation of loco-regional recurrences using DIR after iHD-SBRT in localised pancreatic cancer
Martin Manderlier, Belgium
PO-1380
Management of esophageal cancers .Survey by the AIRO Gastrointestinal Tumors Study Group
Nicola Simoni, Italy
PO-1381
Repeated Magnetic Resonance Image-guided Stereotactic body Radiotherapy for oligometastatic patients
Giuditta Chiloiro, Italy
PO-1382
Neoadjuvant versus definitive chemoradiation for esophageal cancer: a retrospective analysis
reinhilde weytjens, Belgium
PO-1383
Clinical implementation and evaluation of liver SBRT in breath-hold using nasal high flow therapy
Colien Hazelaar, The Netherlands
PO-1388
Prediction of daily GI doses in SBRT for pancreatic cancers using the shortest distance to GTV.
Yusuke Uchinami, Japan
PO-1389
Dose intensification in Locally Advanced Pancreatic Cancer using Robotic SBRT
marianna valzano, Italy
PO-1391